Immunorizon is a startup based in France, 1 tracked investor.
Based in France, Immunorizon is a startup founded in 2023. Brouky records 1 investor associated with the company.
Immunorizon is a biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. Their lead program focuses on a first-in-class antagonist of the IL-7 receptor.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.